Clinical Trial: A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07076550) titled 'A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma' on June 27.

Brief Summary: The goal of this trial is to see if this investigational drug is safe for adult patients with melanoma that has spread to other parts of the body or cannot be removed by surgery. It will also see if this investigational drug can shrink melanoma tumors in the body. The main questions this study aims to answer are:

* What are the side effects of this investigational drug?

* What is the highest dose of this investigational drug that can be given safely?

Participants will:

* Take th...